Dataset from A Two-part, Randomized, Double-blind, Single-dose, Crossover Study to Compare Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Adult Volunteers

This study is comprised of two discrete Parts. Part A is a 3-period cross over evaluating
relative bioavailability. Part B is a 2-period cross over evaluating bioequivalence. There
will be a minimum of a 7-day washout period between treatment periods. Participants will
participate in Part A or Part B, but not both. Approximately 200 participants will be
included in the study.